The standards body, which certifies medical devices under EU rules, is shuttering its medtech unit, creating bottlenecks for companies that need certification services.
Project Farma, ultimately controlled by private equity fund New Mountain Capital, will buy the Carrigaline business, which has nearly €20m in annual revenue.
The Galway company’s attempts to raise a $50m Series C round fell through and a liquidator has been called in just weeks after it published the results of its latest clinical trial.
The Western Development Commission is a frequent investor in medtech in the West of Ireland. The Currency examines the depth of those investments and potential risks of over-reliance.
The Cork start-up was building software for speech and language therapists but struggled to turn its pilots with the HSE and the NHS into commercial contracts.
Megadale makes equipment for the medtech and life-sciences sectors but a cancelled contract by a major multinational forced the company into liquidation.
US medical device maker Teleflex is carving up its business in a series of deals totalling $2bn with private equity firms acquiring the Irish operations.
Aerska raised $21m recently for its RNA therapies tackling diseases like Alzheimer's. Co-founders Jack O’Meara and David Hardwicke talk to The Currency about what’s next.
The start-up, often described as an "Uber for pathology", has just secured a crucial approval to carry out pathological testing in the UK. CEO Donal O'Shea speaks about building out its UK footprint and plans to scale up in the US.
The company was founded by Oxford researchers and run from Ireland. Attempts to reshore it through an examinership have fallen apart, while a separate UK court case looms large.
© 2026 Currency Media Limited
